Trials / Conditions / Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis

26 registered clinical trials studyying Allergic Bronchopulmonary Aspergillosis — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients W NCT07362667	Qianfoshan Hospital	—
Recruiting	Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis NCT07530770	Qianfoshan Hospital	—
Recruiting	iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine NCT06244979	Radboud University Medical Center	Phase 2
Recruiting	A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA NCT07362693	Qianfoshan Hospital	—
Not Yet Recruiting	Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis NCT06645210	Peking University Third Hospital	—
Withdrawn	Allergic Bronchopulmonary Aspergillosis Prescreening Study NCT05903612	Community Pharmacology Services Ltd	—
Recruiting	A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillo NCT06174922	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 3
Recruiting	Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndr NCT05444946	Post Graduate Institute of Medical Education and Research, Chandigarh	N/A
Unknown	A Prospective Study on Optimizing Treatment for ABPA NCT05129033	Shanghai Zhongshan Hospital	N/A
Completed	Immune Profiles in CF Fungal Infection NCT04476758	University of Alabama at Birmingham	—
Completed	Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERT NCT04442269	Regeneron Pharmaceuticals	Phase 2
Completed	Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects NCT04229303	Zambon SpA	Phase 1
Active Not Recruiting	Deflazacort Vs. Prednisolone in Acute-stage ABPA NCT04227483	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 2 / Phase 3
Withdrawn	Benralizumab in the Treatment of Patients With Severe Asthma With ABPA NCT04108962	Baylor Research Institute	Phase 4
Terminated	Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis NCT03960606	Pulmatrix Inc.	Phase 2
Completed	Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractor NCT03059992	Scynexis, Inc.	Phase 3
Completed	Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance T NCT02273661	Poitiers University Hospital	Phase 2
Completed	A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis NCT02440009	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 2 / Phase 3
Completed	Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis NCT01621321	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 2 / Phase 3
Completed	A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary NCT01857479	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 2 / Phase 3
Completed	Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis NCT01321827	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 2 / Phase 3
Completed	Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis NCT01222273	University of Pittsburgh	N/A
Completed	Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary As NCT00974766	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 2 / Phase 3
Terminated	An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Ac NCT00787917	Novartis Pharmaceuticals	Phase 4
Completed	Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA NCT00585364	University of Pittsburgh	—
No Longer Available	Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis NCT05897294	TFF Pharmaceuticals, Inc.	—